Yongin, South Korea

Jong Seong Ahn

This inventor holds 1 USPTO granted patent. Top assignee: Green Cross Vaccine Corporation. Active years: 2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jong Seong Ahn. Retrieved from https://idiyas.com/inventor/jong-seong-ahn

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jong Seong Ahn: Innovator in Diabetes Research

Introduction

Jong Seong Ahn is a notable inventor based in Yongin, South Korea. He has made significant contributions to the field of diabetes research through his innovative work. His expertise and dedication have led to advancements that could potentially improve the lives of many individuals affected by diabetes.

Latest Patents

Jong Seong Ahn holds a patent for "DNA and peptides of a diabetes-specific endogenous retrovirus." This patent represents a crucial step in understanding the relationship between diabetes and viral infections. His work in this area is pioneering and showcases his commitment to addressing critical health issues.

Career Highlights

Ahn is currently employed at Green Cross Vaccine Corporation, where he continues to engage in groundbreaking research. His role at the company allows him to collaborate with other experts in the field and contribute to the development of innovative solutions for diabetes management.

Collaborations

Some of his coworkers include Ji-Won Yoon and Hee-Sook Jun. Their collaborative efforts enhance the research environment and foster innovation within the company.

Conclusion

Jong Seong Ahn's contributions to diabetes research through his patent and work at Green Cross Vaccine Corporation highlight his role as an important inventor in the field. His ongoing efforts are likely to lead to further advancements in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…